Glucagon-like Peptide-1

GLP-1 Drugs: Lower Heart & Kidney Risk in Type 1 Diabetes

by

Beyond Diabetes: GLP-1s Poised to Redefine Cardiovascular & Renal Health Nearly 1.4 million Americans are living with Type 1 diabetes, and for decades, managing the disease has primarily focused on blood sugar control. But a recent wave of research, culminating in studies published in Nature and reported by News-Medical, suggests a far more expansive role … Read more

GLP-1 Drugs & Addiction: Veteran Study Shows Promise

by

Beyond Ozempic: How GLP-1 Drugs Could Rewrite the Future of Addiction Treatment Nearly 31 million Americans aged 12 or older struggled with substance use disorder in 2022. But what if a single class of drugs could not only treat the symptoms of addiction, but fundamentally alter the brain’s reward pathways to prevent cravings from taking … Read more

© 2026 Archyworldys. All rights reserved.

For contact, advertising, copyright, issues email: [email protected]